Drugs with this side effect
- 1,25(OH)2D3
- 5-ASA: postmarketing, uncommon, 3% - 8%
- 5-FU: 1%
- 5-aza-2'-deoxycytidine: 6.06%
- 5-azacytidine: very common, 5.43% - 16.4%
- 5-fluorocytosine
- Anidulafungin: 4.8% - 5.34%
- Azarga
- BCNU: 1% - 5%
- BPTI
- Benicar-HCT
- Bivalirudin: postmarketing, 2.3% - 3.7%
- CAS 76095-16-4: 2.1%
- CAS 76420-72-9
- CGP 19835A: very common, 11%
- Cancidas
- Colimycin M
- Eptifibatide: 0.8% - 2.12%
- Fe(III: postmarketing, 0% - 10%
- Forteo: postmarketing, rare, common
- Gd-DTPA
- Gd-EOB-DTPA
- Ge-132: 14%
- Glat copolymer
- Goserelin
- ICI 182,780: 5% - 7.1%
- Insulin
- K779: 1% - 28%
- Kaluril
- LY146032: 0% - 6.7%
- Leuprorelin: postmarketing
- Lisinopril: 1.1% - 7.4%
- Lovaza
- Lutalyse
- MK-462
- Meropenem anhydrous
- Metrodin
- MnDPDP
- Nafarelin
- NovoLog: 3% - 5%
- Octreotide
- Optison: postmarketing, uncommon
- PGE2
- Photofrin: 0% - 40.4%
- Photofrin II: common
- Revasc
- Romidepsin
- SU5416
- SonoVue
- Stalevo 50
- TMC207: 11.4%
- Terlipressin: postmarketing
- Triptorelin: 1.7%
- UDCA: 3.2% - 5%
- VACV: 21%
- abiraterone: 0% - 0.5%
- acamprosate: frequent
- acebutolol: 1% - 4%
- acetaminophen: 1.33%
- acitretin: postmarketing
- acyclovir
- adefovir dipivoxil
- adenosine: postmarketing
- alendronate: postmarketing
- alfuzosin: postmarketing, uncommon
- almotriptan: infrequent
- alprazolam: frequent, 10.6% - 18.1%
- ambrisentan: 1.49% - 4.62%
- amifostine
- amiloride
- amlodipine
- amlodipine besylate
- amphetamine
- amphotericin B: 11.6% - 12%
- anagrelide: 8%
- anastrozole: 4.85% - 7.32%
- anthracycline: 0% - 9%
- apomorphine: 15%
- apraclonidine: postmarketing
- argatroban: 0.893% - 15.2%
- aripiprazole
- arsenic
- arsenic trioxide: common
- atazanavir: uncommon
- atenolol
- atomoxetine
- atorvastatin: postmarketing
- atropine
- avanafil
- azelastine: postmarketing
- azithromycin
- aztreonam
- baclofen: rare
- benazepril
- bendamustine
- betaxolol: 1.4% - 7.1%
- bexarotene: 10%
- bicalutamide: 6% - 8%
- bimatoprost
- bisoprolol: 1.1% - 2.1%
- bleomycin hydrochloride
- boceprevir: common
- bortezomib
- bosentan: 13%
- bosutinib
- brimonidine
- brinzolamide: postmarketing
- budesonide
- bumetanide
- buprenorphine
- bupropion: infrequent, 1% - 4%
- buspirone: frequent
- busulfan: 26%
- butorphanol
- cabazitaxel
- candesartan
- candesartan cilexetil
- capecitabine: 0.2% - 6%
- captopril
- carbamazepine: 5%
- carbidopa: 0.8% - 1%
- carboprost
- carnitine: 6% - 15%
- carvedilol: 0.1% - 14.4%
- cefaclor
- cefdinir: postmarketing
- cefpodoxime
- cefuroxime
- cefuroxime axetil
- celecoxib
- cerivastatin: 2%
- cetirizine
- cevimeline
- ciclesonide
- cidofovir
- cilazapril: postmarketing
- cilostazol: postmarketing
- cinacalcet: 6%
- ciprofloxacin
- citalopram: postmarketing, infrequent, uncommon, frequent, 1.2%
- cladribine
- clarithromycin: uncommon
- clomiphene citrate: postmarketing
- clomipramine: 4% - 7%
- clonazepam
- clonidine: 5.26%
- clopidogrel
- clozapine: 1%
- colestipol
- colestyramine
- copolymer 1
- cyclobenzaprine: postmarketing
- cyclophosphamide: postmarketing
- cytarabine
- dabigatran etexilate
- dalteparin: 1.53% - 2.31%
- darunavir
- dasatinib: common, 0% - 13%
- delamanid
- delavirdine
- deprenyl: frequent, 2%
- desmopressin
- diatrizoate
- diazoxide
- diclofenac: very rare, postmarketing, 0% - 2%
- diethylenetriaminepentaacetic acid
- diflunisal: postmarketing
- diltiazem
- dipyridamole: 19.7%
- disopyramide
- dobutamine
- docetaxel: postmarketing, uncommon, common
- dofetilide: 10%
- dolasetron
- donepezil: frequent, 2%
- dorzolamide
- doxapram
- doxazosin: 1.2% - 3.8%
- doxepin: infrequent
- doxercalciferol
- doxorubicin: common
- duloxetine
- efavirenz
- entacapone
- epinephrine
- eplerenone
- eprosartan
- ergonovine
- eribulin
- erlotinib: 0% - 18%
- ertapenem
- erythromycin
- erythromycin lactobionate
- eslicarbazepine acetate
- esmolol
- esomeprazole magnesium
- estazolam: 1%
- estradiol: postmarketing, 1.12% - 4.49%
- estramustine: 1%
- estramustine phosphate
- ethotoin
- etoricoxib
- everolimus: 5%
- exemestane: 2-5%
- exenatide
- ezetimibe: 1.8% - 3.4%
- famotidine
- febuxostat
- felbamate: 2.6%
- felodipine
- fenofibrate: 1.9%
- fenoldopam
- fentanyl
- ferumoxytol: postmarketing, 0.7% - 1.3%
- fesoterodine
- flecainide: 1% - 5.4%
- fludarabine: 0% - 5%
- flumazenil
- flunisolide
- fluorescein: postmarketing
- fluoxetine: frequent
- flurazepam
- fluticasone propionate
- fluvastatin: 0.2% - 1.4%
- fluvoxamine: infrequent, 3%
- fondaparinux: rare, 0.727% - 1.84%
- formoterol: 1.9% - 7%
- foscarnet
- fosinopril: uncommon
- fosinoprilat
- frovatriptan
- gabapentin: postmarketing, infrequent
- gadobenate dimeglumine
- gadodiamide
- gadofosveset
- gadolinium: postmarketing, 0.1%
- gadoteridol: 0.08%
- gadoversetamide
- galantamine: frequent
- ganciclovir: 3.4% - 4.4%
- gatifloxacin
- gemcitabine
- gemeprost
- gemfibrozil: 2.1%
- gliclazide
- glutamine: 0% - 18.8%
- granisetron
- guanfacine: postmarketing
- halofantrine
- hetastarch: postmarketing
- histamine
- hydrochlorothiazide
- hydromorphone: 2.06%
- hydroxocobalamin
- hydroxybutyrate
- ibandronate
- icodextrin: 4% - 5%
- idarubicin
- ifosfamide: postmarketing
- iloprost
- imatinib: uncommon, 0.4% - 11%
- imiquimod: postmarketing, 0% - 1.08%
- indacaterol: common
- indapamide: 2%
- indinavir
- indomethacin
- insulin detemir
- iodide
- iodixanol: 1.1% - 4.3%
- iopamidol
- iopromide
- ioversol
- ipratropium bromide: 0.7% - 4.2%
- irbesartan: uncommon
- irbesartan-hydrochlorothiazide
- iron sucrose: 6.1%
- isomannide
- isosorbide-5-mononitrate
- isoxsuprine
- isradipine: 2.4% - 2.9%
- itraconazole: 0% - 3%
- ivermectin: 0% - 7%
- ixabepilone: 0% - 5%
- ketorolac: postmarketing
- ketorolac tromethamine: postmarketing
- lacosamide: 0% - 12%
- lamivudine
- lamotrigine: 2% - 5%
- lanreotide
- lansoprazole
- lasofoxifene: uncommon
- latanoprost
- leflunomide: 1% - 4%
- lenalidomide: postmarketing, uncommon, 8.22%
- lercanidipine
- letrozole: 3% - 9%
- levetiracetam: 1.3%
- levobunolol
- levodopa/carbidopa: 1%
- levonorgestrel
- lidocaine
- lomefloxacin
- lomitapide
- loratadine
- losartan: 1.1% - 12%
- lovastatin
- mannitol
- medroxyprogesterone: postmarketing
- medroxyprogesterone acetate: postmarketing
- mefloquine: postmarketing
- megestrol
- melatonin
- melphalan
- memantine: postmarketing
- meropenem
- mesna: 7.6% - 10%
- metaproterenol: 0.2% - 1%
- metformin
- methotrexate
- methylene blue
- methylergometrine
- methylphenidate: postmarketing
- methysergide
- metolazone: 2.7%
- metoprolol: postmarketing
- metronidazole
- mexiletine: 1.3% - 7.5%
- milnacipran: 2% - 3%
- milrinone
- mirtazapine: postmarketing
- misoprostol: postmarketing
- mitoxantrone
- moclobemide
- modafinil: postmarketing
- moexiprilat
- mometasone
- mometasone furoate
- morphine: 2%
- moxifloxacin
- mycophenolate mofetil: 13.2% - 26.3%
- mycophenolic acid: 26% - 26.3%
- nabilone: postmarketing
- nadolol
- naltrexone: postmarketing
- naproxen
- natamycin
- nebivolol: 0% - 1%
- nedocromil sodium
- nefazodone
- nelarabine: 0% - 5%
- nicardipine: 0.6% - 0.7%
- nicorandil: common
- nicotine
- nifedipine: postmarketing, 1.1%
- nilotinib: uncommon, common
- nilutamide
- nisoldipine: 2%
- nitrofurantoin
- nizatidine: 1.9% - 2.3%
- norfloxacin
- ofloxacin
- olanzapine: 3% - 4%
- olmesartan: common, 0.379% - 1.05%
- olmesartan medoxomil
- olsalazine
- omeprazole: postmarketing
- ondansetron: postmarketing, uncommon, 2.19%
- orlistat: uncommon
- oxaliplatin: common, 1% - 5%
- oxcarbazepine: 0% - 2%
- oxybutynin: 1.3%
- oxycodone
- oxymorphone
- paclitaxel: postmarketing, very common
- paliperidone
- pantoprazole
- paricalcitol: 2.8% - 3%
- paroxetine: common, 1%
- pazopanib: 0% - 10%
- pegaptanib
- pegaptanib sodium
- pemetrexed: 1% - 40%
- pentamidine
- pentostatin
- pentoxifylline: 0.3% - 1.1%
- pergolide: frequent, 3.7%
- perindopril: 2.4%
- perindopril erbumine: 2.4%
- phentolamine: uncommon
- phenylephrine
- pilocarpine
- pimozide
- pindolol: 1% - 3%
- pioglitazone: 5.1%
- pirbuterol: 0% - 1.3%
- piroxicam
- pixantrone
- posaconazole
- pramipexole: 3%
- pravastatin: 0.3% - 10%
- pregabalin: 1% - 4%
- progesterone: 4%
- propafenone: postmarketing, 0.2% - 2%
- propofol
- prostacyclin: 11%
- quetiapine
- quinapril: 2.4%
- quinaprilat: 2.4%
- quinidine
- rabeprazole
- raloxifene: 0.5% - 4%
- ramipril: 0.7% - 2%
- ranitidine
- rapamycin: 12% - 24%
- rasagiline
- rasburicase
- regadenoson: very common, 7% - 19%
- repaglinide: 1% - 2%
- retinoic acid
- ribavirin: common, 5% - 12%
- rifabutin: 1%
- rifapentine
- rifaximin
- riluzole
- risedronate: 1.2% - 6.6%
- risperidone: frequent, 0.8% - 3%
- ritonavir
- rivaroxaban
- rivastigmine: rare, infrequent, frequent
- rizatriptan: 2% - 3%
- rofecoxib
- ropinirole: frequent, 4%
- ropivacaine: 0.5% - 2.9%
- salbutamol: postmarketing, 0% - 1.7%
- salmeterol
- salmon calcitonin acetate: postmarketing
- samarium: 4.02%
- saquinavir
- sertraline: postmarketing, common, frequent
- sevelamer hydrochloride
- sibutramine
- sildenafil: postmarketing, uncommon
- simvastatin
- sodium
- sodium cromoglycate
- sodium ferric gluconate: 0.5% - 10%
- sodium iodide
- sofosbuvir: common
- sotalol: postmarketing, 1% - 16%
- sparfloxacin
- sulindac
- sumatriptan: 1% - 3%
- sunitinib
- tacrolimus: 13% - 19%
- tadalafil: postmarketing, 6%
- tamoxifen: 4.85% - 6.47%
- tamsulosin: 0.5% - 4.07%
- technetium-99m: 0% - 2.63%
- teduglutide
- tegaserod
- telmisartan: postmarketing, rare, uncommon, common, 1.3%
- temsirolimus
- teniposide
- tenofovir: 3%
- tenofovir disoproxil fumarate: 3%
- terazosin: 1.5%
- terbinafine: very rare
- tesamorelin: 1.1%
- testosterone: postmarketing
- testosterone undecanoate
- tetraen
- thalidomide
- thymidine
- tiagabine: frequent
- tiaprofenic acid
- ticagrelor: 3.1% - 3.5%
- tigecycline
- timolol: 0.6%
- tiotropium: 2% - 7%
- tobramycin: 26%
- tolcapone: 3%
- tolmetin
- tolterodine: 3.4%
- topiramate: 1% - 4.4%
- topotecan: 0.3% - 2%
- torasemide: 1.2%
- toremifene
- tramadol
- trandolapril
- trandolaprilat
- tranexamic acid
- travoprost
- trazodone
- treprostinil
- triazolam
- trospium chloride: postmarketing
- trovafloxacin
- v 1784: postmarketing, 4% - 6%
- valdecoxib
- valproate
- valrubicin
- valsartan
- vandetanib: 0.4%
- vardenafil
- varenicline: uncommon, frequent
- venlafaxine
- verapamil: postmarketing
- verteporfin
- vigabatrin: 1% - 5%
- vinflunine
- vinorelbine
- voriconazole: common, 0% - 2.04%
- vorinostat
- warfarin
- x M22
- zaleplon: frequent
- ziconotide
- zidovudine: postmarketing, rare, 2.13% - 6.38%
- zidovudine/lamivudine
- zileuton
- ziprasidone: rare, 3%
- zoledronic acid: uncommon, 1.3% - 2.4%
- zolmitriptan: infrequent, 2% - 5%
- zolpidem: infrequent, 1%
- zonisamide: infrequent
- zopiclone: frequent
|
Drugs with this indication
|
